Extremely disappointed. DNA has had a bucket load of issues over the last couple of years and the bad news just keeps coming.
The intel of management must be quite weak as many of the concerns and problems should have been identified and rectified well before they become monsters.
Communication is deplorable too as some of these points and issues could have been communicated to shareholders well before waiting for an AGM.
It seems the only positive is the anomaly of a statistical higher than average theoretical win rate in November. That's just a blip.
I don't know whether the company is stupendously unlucky or the management is to blame. I think it's weak management and unlucky.
The frustrating part is that in theory there is massive upside. I just don't know now whether these guys are up to the job to execute it.
AGM, page-19
Add DNA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.23M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8884 | 3.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.12pm 19/07/2024 (20 minute delay) ? |
| DNA (ASX) Chart |
Day chart unavailable